Wednesday, September 13, 2017 10:04:28 PM
I only deal in fins. Show me a 10-K/Q and my tone will change. I have no shame in standing behind facts.
Are you saying revenue will exceed expenses? I’ll take that bet - I disagree wholeheartedly. There will always be “a reason” as to why SG&A exceeds revenue: “Next quarter”.
As long as Derek and friends can Svengali the early OTC investors, they’ll continue this carrot on a stick game. Once that gig is up and public sentiment changes, there will be an R/S to wipe their hands clean and possibly make something real. It’s a shame because this is literally OTC 101, but folks refuse to listen to anyone except their fearless leader: Derek Peterson.
JMO,
SSC
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM